Skip to main content
Springer logoLink to Springer
. 2025 Apr 8;32(17):11097–11113. doi: 10.1007/s11356-025-36342-2

Biomarkers of exposure to polycyclic aromatic hydrocarbons in urine of municipal police officers: impact of inhalation on total exposure

Veronika Gomersall 1, Katerina Ciglova 1, Ondrej Parizek 1, Andrea Rössnerova 2, Pavel Rössner Jr 2, Radim J Sram 3, Jan Topinka 2, Jana Pulkrabova 1,
PMCID: PMC12014768  PMID: 40199782

Abstract

Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous environmental contaminants that adversely affect human health, mainly through their carcinogenic and mutagenic properties. Monitoring the exposure to PAHs of the inhabitants of air polluted regions is important because of the impact of these pollutants on human health. The aim of this study was to assess the exposure to PAHs of municipal police officers (non-smokers) living in three localities in the Czech Republic (strategically selected according to the level of air pollution) and determine how air pollution impacts personal exposure to PAHs via inhalation. Twenty PAHs were determined in the inhaled air collected from personal air samplers. Simultaneously, the total exposure to PAHs was investigated by evaluating the concentrations of 11 monohydroxylated polycyclic aromatic hydrocarbons (OH-PAHs) in urine samples. Despite the observed differences in the concentrations of PAHs in the air from the personal samplers between the three locations, no statistically significant differences were found in the concentrations of OH-PAHs in the urine samples. Outcomes of this study indicate that inhalation exposure is not the primary source of PAHs exposure for Czech municipal police officers, but that diet may also be an important contributor to total body burden. The levels of OH-PAHs found in urine of Czech municipal police officers were very similar to those found in the urine of the Czech mothers from our previous study. This study provided the data about the body burden of potentially occupationally exposed group that has not yet been studied in the Czech Republic.

Graphical abstract

graphic file with name 11356_2025_36342_Figa_HTML.jpg

Supplementary Information

The online version contains supplementary material available at 10.1007/s11356-025-36342-2.

Keywords: Air pollution, Biomonitoring, Czech Republic, GC–MS/MS, Personal air samplers, UHPLC − MS/MS, Urine analysis, PAHs

Introduction

Polycyclic aromatic hydrocarbons (PAHs) are well-known and studied environmental contaminants that are formed during the pyrolysis and pyrosynthesis of organic matter and indicate the level of air pollution from anthropogenic sources (such as heavy industry, exhaust fumes or local heating systems) and non-anthropogenic sources (such as volcanic activity or forest fires) (Purcaro et al. 2013; Abdel-Shafy and Mansour 2016). These contaminants are also formed in food during culinary practices such as grilling or smoking. They can also enter food from a contaminated environment, by sorption from soil, or by deposition of particulate matter (PM) from the air (EFSA 2008).

Human exposure to these substances is associated with adverse human health effects. Of most significant concern is the carcinogenicity of some of the PAHs’ reactive metabolites, e.g. benzo(a)pyrene (BaP), which, due to its reactive metabolites, is included in the database of the International Agency for Research on Cancer (IARC) as carcinogenic to humans (Group 1) (IARC 2021). Higher exposure to PAHs has been associated with an increased risk of lung, skin or gastrointestinal cancers (Sun et al. 2021; Ravanbakhsh et al. 2023). Additionally, reactive metabolites of some PAHs show toxicity, mutagenicity and teratogenicity and can also act as endocrine disruptors. Higher human exposure to PAHs is also linked with a higher incidence of childhood obesity (Poursafa et al. 2018; Bushnik et al. 2020), respiratory problems (Sram et al. 2013) and male infertility (Xia et al. 2009; Yang et al. 2017).

Given the different sources of PAHs, exposure pathways and the load of the body burden are influenced by aspects such as occupation, lifestyle, diet and place of residence. In the case of non-smokers, the diet accounts for 70% (EFSA 2008) to 90% (Polachova et al. 2020) of overall exposure. Another source of PAHs contributing to overall human exposure is polluted air from local sources such as industry, heating by burning wood/coal or traffic (Duan et al. 2014; Li et al. 2010). For occupationally exposed workers, dermal exposure can also be a significant contributor to total exposure along with inhalation (Louro et al. 2022).

The load of the body burden can be assessed by environmental monitoring followed by estimation of daily intake. Dietary exposure to PAHs is investigated by analysing either individual food items or food duplicates of participants’ everyday diets (Polachova et al. 2020). For the estimation of inhalation exposure, analysing the airborne PAHs, sampled by stationary high-volume air samplers (Polachova et al. 2020) or personal air samplers (Duan et al. 2014; Nethery et al. 2012; Perico et al. 2010), is applied. The second technique provides more accurate information about the levels of airborne PAHs to which the person has been actually exposed through the whole sampling period. Another approach to assessing the human body burden of PAHs is human biological monitoring. By measuring biomarkers in human urine, it is possible to determine recent total exposure to PAHs. The primary metabolites excreted in urine are monohydroxalated PAH (OH-PAH) conjugates, usually used as exposure biomarkers (Onyemauwa et al. 2009). Biomonitoring data provides more accurate information for assessing the total human body burden of PAHs, which might be used in public health research to determine what levels of PAHs might be associated with potential adverse effects on human health (Koch et al. 2014; Li et al. 2010).

However, the biomonitoring data provides no information specific to the route. Thus, in studies of particular cohort groups with a potential high risk of exposure via inhalation, the combination of both is beneficial for assessing the origin of human exposure (Li et al. 2010). In this study, we focus on exposure of municipal police offices with residency in three localities of the Czech Republic (air-polluted location, capital city and control group). This potentially occupationally exposed group spent the vast majority of their working hours outdoors and thus been exposed to airborne PAHs from the urban environment contaminated by industry, traffic or local heating. For evaluation on how local air pollution impacts personal exposure of participants to PAHs, the analysis of 11 biomarkers in their one-spot urine and the analysis of 20 airborne PAHs sampled by personal air samplers was conducted. This study also provides a knowledge about the exposure to PAHs of the inhabitants of one of the most air polluted area in the Czech Republic— Ostrava.

Materials and methods

Standards, chemicals and other materials

The list of certified standards, chemicals and other materials used and their manufacturers are given in Table S1 and Table S2. For OH-PAHs, calibration solutions (n = 13) were prepared in concentrations of 0.01–100 ng/mL in methanol with a concentration of isotopically labelled standards of 10 ng/mL and stored in the freezer (− 20 °C). The Standard Reference Material® (SRM) 3673 applied for the validation experiments was purchased from the NIST (USA). The PAHs working solutions (n = 8) were made in 0.05–100 ng/mL concentrations with isotopically labelled standards of 2 ng/mL and stored in a refrigerator (5 °C).

Sample collection

All samples were provided by the Institute of Experimental Medicine (IEM), Academy of Sciences of the Czech Republic in Prague and the University of Ostrava as part of the molecular-epidemiological study to assess the impact of air pollution on the genome of municipal police officers. This study is part of the Healthy Aging in Industrial Environment (HAIE) project (HAIE n.d), which focuses on the effects of specific environmental and lifestyle risk factors on population health and ageing in industrial regions. The Ethics Committee of IEM approved the study. Each participant signed a written consent form and completed a questionnaire about personal information, long-term exposure, diet and short-term exposure. All participants were non-smoking males. Smokers and subjects with medical treatment were not included in the study. Tables 1 and 2 show the key information about them.

Table 1.

Key information on the municipal police officers

Ceske Budejovice Prague Ostrava
February–March 2019 September–October 2019 February–March 2019 September–October 2019 February–March 2019 September–October 2019
Number of participants 17 16 60 56 56 54
Agea 38 38 38 39 42 42
(22–48) (22–48) (23–63) (23–63) (21–61) (21–61)
BMIa 28 28 29 29 28 28
(23–41) (23–41) (19–37) (19–37) (20–45) (20–45)
Duration of time spent in current job (years)a 7.8 (0.8–26.6) 16.0 (0.8–26.8) 11.5 (1.0–25.9)
Residency in the region of study city (years/age)a 1.0 (0.2–1.0) 0.3 (0.0–1.0) 1.0 (0.6–1.0)
Preferred dietb Plant-based 0% 0% 0%
Meat-based 24% 17% 7%
Mixed 76% 83% 93%
Preferred food preparationb Boiling/steaming 18% 30% 32%
Frying/barbequing 6% 2% 5%
No preference/all type above 76% 65% 66%
Preferred style of cookingb Gas/electric cooker 100% 100% 98%
Stove 0% 0% 2%

BMI body mass index

aMedian (min–max)

b% of participants (from first round)

Table 2.

Short-term exposure of municipal police officers (first sampling round)

Time spent… (hours) … at home (inside) … at work (inside) TOTAL inside … at traveling to work … at home (outside) … at work (outside) TOTAL outside
Median (min–max) Ceske Budejovice 10 3 12 1 2 9 11
(5–15) (0–13) (8–22) (0–2) (0–6) (0–13) (0–15)
Praha 11 3 14 1 0 9 9
(6–20) (0–12) (10–23) (0–5) (0–6) (0–12) (0–12)
Ostrava 11 2 14 1 0 9 9
(9–14) (0–12) (10–22) (0–2) (0–3) (0–12) (0–13)

Sampling was conducted in two periods with the same participants, February–March 2019 (1st period) and September–October 2019 (2nd period). Sampling was conducted in three regions of the Czech Republic—Ceske Budejovice (control location), Prague (capital city) and Ostrava (air-polluted location)—which were strategically selected according to the level of air pollution (CHMI 2018). The place with the highest air pollution was Ostrava due to heavy industrial activity in the surrounding area and local heating. Prague was chosen as a densely populated and heavily trafficked capital city, and Ceske Budejovice was selected as a control location.

Ambient air was sampled using personal air samplers—Active PV 1.7 monitors (URG Corp, Chapel Hill, NC, USA) were fit out with Teflon-impregnated glass fibre filters (T60A20, Pallflex) and collected PM2.5 particles (Williams et al. 1999). The volume of air sampled ranged from 2 to 3 m3 per sampling period (24 h). The personal air samplers were attached to the officer’s clothing near their faces for 24 h. The urine samples were collected from healthy non-smoking policemen at the end of their shifts into 50-mL tubes (Greiner Bio-one, Kremsmünster, Austria). The 259 urine samples and 259 filters collected were frozen (–20 °C) before analysis.

Methods

Analysis of OH-PAHs in urine samples

Extraction of hydrolysed urine samples by shaking with ethyl acetate followed by a purification step by dispersive solid-phase extraction (d-SPE, with sorbent Z-Sep) is described in detail by Lankova et al. (2016). More detailed information on the analysis can be found in the Supplementary Material. The quantitative and qualitative transitions are shown in Table S3. Creatinine levels were used to normalise urine sample dilution in each sample, and these levels were determined using Jaffe’s spectrophotometric method (Lankova et al. 2016).

Analysis of PAHs in filter samples

A filter for air sampling was extracted in a glass test tube with 10 mL of the solvent mixture of dichloromethan:n-hexane (1:3, v/v) supported by ultrasonic (2 × 30 min). The combined crude extracts were evaporated to near dryness and finished with a gentle stream of nitrogen. The residue was dissolved in 250 µL of an isotopically labelled standard of PAHs (at a concentration of 2 ng/mL) in isooctane. More detailed information on the analysis can be found in the Supplementary Material.

Quality assurance/quality control and validation

OH-PAHs in urine samples

The analytical method for the analysis of 11 OH-PAHs and the spectrophotometric Jaffe’s method for the determination of creatinine concentration were validated using the NIST SRM 3673. For the compounds not certified in the SRM 3673 (chrysene-6-ol (6-OH-CHR) and benzo[a]pyrene-3-ol (3-OH-BaP)), the performance characteristics were determined by analysing the artificially contaminated urine blank sample, measured before validation to ensure that 6-OH-CHR and 3-OH-BaP were not naturally present in this sample. For performance characteristics of the UHPLC-MS/MS method, see Table S4.

To compensate for losses during extraction and also for unexpected matrix effects, isotopically labelled analogues were used (in the case of 6-OH-CHR [2H]9-pyrene-1-ol (d9−1-OH-PY)) and in the case phenanthrene-4-ol (4-OH-PHE) [2H])8-phenanthrene-9-ol (d8−9-OH-PHE) were used). Background contamination for all target analytes was controlled by the procedural blank. Sample with 5 mL of deionised water and one sample in two replicates were prepared simultaneously with each batch of samples. The contamination level found in the blank sample was subtracted from each sample prepared in the same batch. The blank samples contained traces of naphthalene-1-ol (1-OH-NAP), naphthalene-2-ol (2-OH-NAP) and pyrene-1-ol (1-OH-PY) (concentrations below 0.03 ng/mL urine). These are common contaminants caused by traces of OH-PAHs in the solvents and ambient air.

PAHs in filter samples

The analytical method for analysing 20 PAHs was validated through artificially contaminated unused air sampling filters. For performance characteristics of the GC–MS/MS method, see Table S5.

For the compensation matrix effects, isotopically labelled analogues were used (in the case of benzo[c]fluorene (BcFL) 13C3-pyrene (13C3-PY), cyclopenta[c,d] (CPP) and 5-methylchrysene (5MC) 13C6-chrysene (13C6-CHR), benzo[j]fluoranthene (BjFA) 13C4-benzo[a]pyrene (13C4-BaP), dibenzo[a,l]pyrene (DBalP) and dibenzo[a,h]pyrene (DBahP) 13C12-dibenzo[a,i]pyrene (13C12-DBaiP) were used). Before the sampling, a non-used filter for air sampling was analysed to check for possible contamination by PAHs. With each batch of samples, background contamination was tested by preparing a procedural blank. The concentration of contamination in the blank sample was subtracted from all samples prepared on the same day. It contained traces of phenanthrene (PHE), fluoranthene (FLA) and pyrene (PY) (average concentrations ranged from 0.05 to 0.4 ng/filter). These are common contaminations caused by traces of PAHs in the solvents and in the ambient air.

Health risk analysis

Toxicity equivalent concentration (TEQ; given by Eq. 1 and Eq. 2) and inhalation cancer risk (ICR; given by Eq. 3) were used to assessed the human respiratory risk from exposure to PM2.5-bound PAHs. Toxic equivalent factor (TEF) values from the Nisbet and LaGoy (1992) study and the IURBaP value 8.7 × 10−5 ng/m3 given by the World Health Organisation (WHO 2000) were used.

TEQ=ici×TEFi 1
TEQ=0.001PHE+FLA+PY+0.01AN+CHR+BghiP+0.1BaA+BbF+BkF+IP+BaP+DBahA 2
ICR=TEQ×IURBaP 3

Statistical analysis

The concentrations of the measured 11 OH-PAHs in urine samples are stated in the concentration ratio OH-PAH/creatinine to compensate for differences between the hydration status of each municipal police officer. The results for PAHs in filter samples were calculated as the analyte concentration in the sample (ng/mL of solvent) divided by the total volume of air sampled (m3). For results below limit of quantification (LOQ) and with ≥ 50% positive samples (for 259 samples), a value ½ of LOQ was used to calculate the arithmetic mean, median and 5th and 95th percentile.

A logarithmic transformation was performed before each univariate statistical test to provide a normal data distribution. Analysis of variance (one-way ANOVA) followed by Tukey–Kramer’s post hoc test was used to determine statistically significant differences in the concentrations of the monitored compounds between groups of samples varying in geographic location and durations of time outdoors. A paired two-sample t-test was applied to evaluate interindividual differences in sampling periods. The Pearson’s correlation coefficient was used to determine correlations between individual exposure to parent compounds and levels of their metabolites in the urine.

Results

Concentrations of OH-PAHs in urine

Evaluation of 11 OH-PAHs in the urine of municipal police officers (February–March 2019 (1st period): n = 133; and September–October 2019 (2nd period): n = 126) living in three locations of the Czech Republic was performed. Summary information on measured concentrations (µg/g creatinine) is presented in Table 3.

Table 3.

Measured concentrations (µg/g creatinine) of nine OH-PAHs in the urine of municipal police officers sorted by sampling periods

µg/g creatinine LOQs February–March 2019 (1st period)—ALL PARTICIPANTS September–October 2019 (2nd period)—ALL PARTICIPANTS
n = 133 n = 126
Positive samples (%) Arithmetic mean Median 5th Percentile 95th Percentile MIN MAX Positive samples
(%)
Arithmetic mean Median 5th Percentile 95th Percentile MIN MAX
2-OH-NAP 0.001 100 5.17 3.07 1.21 17.7 0.833 27.0 100 5.00 3.99 1.29 10.8 0.738 28.7
1-OH-NAP 0.002 88 0.511 0.309 0.009 1.69 0.0377 3.93 100 1.30 0.530 0.111 4.84 0.0471 21.2
2-OH-FL 0.001 95 0.429 0.312 0.011 1.177 0.0129 2.26 100 0.508 0.332 0.134 1.29 0.100 7.05
2-OH-PHE 0.001 99 0.103 0.072 0.028 0.290 0.0116 0.595 100 0.173 0.120 0.048 0.525 0.0418 0.96
3-OH-PHE 0.001 99 0.141 0.102 0.034 0.399 0.0136 0.901 100 0.161 0.106 0.040 0.422 0.0189 1.36
1-OH-PHE 0.002 100 0.262 0.185 0.070 0.793 0.0455 1.84 100 0.319 0.212 0.082 0.896 0.0439 2.03
9-OH-PHE 0.005 98 0.089 0.059 0.025 0.258 0.0170 0.517 99 0.155 0.086 0.034 0.575 0.0240 1.82
4-OH-PHE 0.001 89 0.030 0.021 0.004 0.090 0.00330 0.169 90 0.050 0.030 0.004 0.178 0.00605 0.396
1-OH-PY 0.002 86 0.106 0.076 0.009 0.308 0.0160 0.838 94 0.118 0.097 0.016 0.303 0.0366 0.461

Values are rounded to three significant figures and maximum three decimal places; LOQs limit of quantification (calculated with mean concentration of creatinine 1.40 mg/mL); for results below LOQ and with more than 50% positive samples, a value ½ of LOQ was used for calculation of arithmetic mean, median, 5th and 95th percentile. Abbreviations of analytes: naphthalene-1-ol (1-OH-NAP), naphthalene-2-ol (2-OH-NAP), fluorene-2-ol (2-OH-FL), phenanthrene-1-ol (1-OH-PHE), phenanthrene-2-ol (2-OH-PHE), phenanthrene-3-ol (3-OH-PHE), phenanthrene-4-ol (4-OH-PHE), phenanthrene-9-ol (9-OH-PHE), pyrene-1-ol (1-OH-PY), benzo[a]pyrene-3-ol (3-OH-BaP), chrysene-6-ol (6-OH-CHRY)

Out of 11 target analytes, only nine were found in quantifiable concentrations. The analytes 6-OH-CHR and 3-OH-BaP were not detected in any samples. The analyte 2-OH-NAP exhibited the highest concentrations of the mean (1st period, 3.07 µg/g creatinine; 2nd period, 3.99 µg/g creatinine) followed by its isomer 1-OH-NAP and fluorene-2-ol (2-OH-FL) (1st period, 0.309 and 0.530 µg/g creatinine; 2nd period, 0.312 and 0.332 µg/g creatinine, respectively).

Figure 1 shows the results of urinary concentration of the sum of the nine OH-PAHs (∑9 OH-PAHs) sorted by geographical location and sampling period.

Fig. 1.

Fig. 1

Comparison of urinary concentrations of ∑9 OH-PAHs sorted by demographic location in both sampling periods. Note: CB = Ceske Budejovice, PR = Prague, OS = Ostrava; median = the horizontal line in the box; arithmetic mean = the cross in the box; 75th and 25th quartiles = the upper and lower limits of the box; 1.5 × the interquartile range = the length of the whiskers, outside dots = outliers; for results below LOQ and with more than 50% positive samples, a value ½ of LOQ was used

Within the 1st sampling period, 133 urine samples from municipal police officers were analysed. The median concentration of ∑9 OH-PAHs (5th–95th percentile) in the urine samples from Ceske Budejovice (n = 17) was 5.52 µg/g creatinine (2.63–14.9 µg/g creatinine), from Prague (n = 60) 4.15 µg/g creatinine (1.99–21.5 µg/g creatinine) and from Ostrava (n = 56) 5.84 µg/g creatinine (2.41–15.8 µg/g creatinine). A total of 126 urine samples from the same municipal police officers were analysed in the 2nd sampling period. The median concentration of ∑9 OH-PAHs (5th–95th percentile) in the urine samples from Ceske Budejovice (n = 16) was 5.54 µg/g creatinine (2.90–22.2 µg/g creatinine), from Prague (n = 56) 5.37 µg/g creatinine (2.08–12.8 µg/g creatinine) and from Ostrava (n = 54) 6.92 µg/g creatinine (2.72–22.7 µg/g creatinine). No statistically significant difference in the measured concentrations of ∑9 OH-PAHs in urine was found between geographical locations in both sampling periods (one-way ANOVA test; detailed results are presented in Table S6).

Concentrations of particulate phase PAHs in inhaled air by individuals

To assess the extent of exposure by inhalation, 20 PM2.5-bound PAHs were monitored in inhaled air by individual municipal police officers in three locations of the Czech Republic (1st period: n = 133; and 2nd period: n = 126) using personal samplers. The results of all participants sorted by sampling period are summarised in Table 4.

Table 4.

Measured concentrations for each PM2.5-bound PAHs in inhaled air of individual (ng/m3) sorted by the sampling periods

ng/m3 LOQs FebruaryMarch 2019 (1st period)—ALL PARTICIPANTS SeptemberOctober 2019 (2nd period)—ALL PARTICIPANTS
n = 133 n = 126
Positive samples (%) Arithmetic mean Median 5th Percentile 95th Percentile MIN MAX Positive samples (%) Arithmetic mean Median 5th Percentile 95th Percentile MIN MAX
PHE 0.050 51 0.075 0.052 0.025 0.228 0.051 0.725 68 0.173 0.113 0.025 0.505 0.052 0.622
AN 0.050 4 - - - - 0.070 0.101 0 n.d n.d - -
FLA 0.050 75 0.114 0.085 0.025 0.278 0.050 0.670 63 0.132 0.080 0.025 0.376 0.050 1.06
PY 0.050 86 0.163 0.131 0.025 0.415 0.050 0.993 71 0.203 0.095 0.025 0.476 0.052 3.18
BcFL 0.050 3 - - - - 0.096 0.296 0 n.d n.d - - - -
BaA 0.050 83 0.143 0.106 0.025 0.288 0.050 1.77 67 0.117 0.089 0.025 0.316 0.055 0.517
CPP 0.050 96 0.345 0.244 0.054 0.778 0.052 5.09 77 0.157 0.122 0.025 0.392 0.057 1.10
CHR 0.050 88 0.179 0.129 0.025 0.373 0.058 1.55 81 0.180 0.128 0.025 0.483 0.053 0.675
5MC 0.050 0 n.d n.d - - - - 0 n.d n.d - - - -
BbF 0.050 96 0.343 0.256 0.077 0.748 0.069 4.38 97 0.357 0.274 0.061 0.979 0.052 1.38
BkF 0.050 83 0.170 0.120 0.025 0.383 0.053 2.72 75 0.171 0.130 0.025 0.476 0.050 0.699
BjF 0.050 86 0.188 0.130 0.025 0.421 0.051 2.53 80 0.248 0.185 0.025 0.627 0.053 0.954
BaP 0.050 97 0.321 0.231 0.078 0.752 0.057 5.18 96 0.378 0.274 0.053 0.976 0.050 1.67
IP 0.050 96 0.308 0.229 0.057 0.609 0.054 4.43 94 0.353 0.267 0.032 0.846 0.052 1.43
DBahA 0.050 18 - - - - 0.055 1.27 53 0.082 0.060 0.025 0.213 0.051 0.369
BghiP 0.050 98 0.369 0.277 0.085 0.691 0.050 5.43 98 0.401 0.315 0.065 0.976 0.052 1.53
DBaIP 0.050 0 n.d n.d - - - - 0 n.d n.d - - - -
DBaeP 0.100 2 - - - - 0.328 1.03 0 n.d n.d - - - -
DBaiP 0.100 1 - - - - 0.383 0.383 0 n.d n.d - - - -
DBahP 0.100 0 n.d n.d - - - - 0 n.d n.d - - - -

Values are rounded to three significant figures and maximum three decimal places; LOQs limit of quantification; for results below LOQ and with more than 50% positive samples, a value ½ of LOQ was used for calculation of arithmetic mean, median, 5th and 95th percentile. Abbreviations of analytes: phenanthrene (PHE), anthracene (AN), fluoranthene (FLA), pyrene (PY), benzo[a]anthracene (BaA), chrysene (CHR), benzo[b]fluoranthene (BbF), benzo[k]fluoranthene (BkF), benzo[a]pyrene (BaP), dibenzo[a,h]anthracene (DBahA), indeno[1,2,3-cd]pyrene (IP), benzo[g,h,i]perylene (BghiP), benzo[c]fluorene (BcFL), cyclopenta[c,d]pyrene (CPP), 5-methylchrysene (5MCH), benzo[j]fluoranthene (BjF), dibenzo[a,l]pyrene (DBalP), dibenzo[a,e]pyrene (DBaeP), dibenzo[a,i]pyrene (DBaiP), dibenzo[a,h]pyrene (DBahP)

Out of 20 target analytes, only 17 were found in quantifiable concentrations. The analytes 5-methylchrysene (5MCH), dibenzo[a,i]pyrene (DBaiP) and DBahP were not detected in any samples. Only in ≤ 4% of all samples collected in the 1st period were the analytes anthracene (AN), BcFL, dibenzo[a,e]pyrene (DBaeP) and DBaiP found. According to the results from personal samplers, the municipal police officers, for whom analytes DBaeP and DBaiP were found in their filters, were exposed to the highest concentrations of Σ20 PAHs (19.0 and 36.0 ng/m3) from the entire group of participants. The individually measured concentrations of Σ20 PAHs ranged from 0.325 to 36.0 ng/m3.

Individual measured concentrations for the analyte benzo[a]pyrene (BaP) varied between < 0.050 and 5.19 ng/m3 for each sampling period and location. The European average emission limit value of 1 ng/m3 (Standards-Air Quality-Environment-European Commission n.d) was exceeded in four filter samples from personal air samplers of municipal police officers in Ostrava (1st period) and in five samples of filters from personal air samplers of municipal police officers in Prague (2nd period).

Figure 2 shows the results of Σ20 PAHs in the inhaled air of municipal police officers sorted by demographic location and sampling period.

Fig. 2.

Fig. 2

Comparison of concentrations of Σ20 PAHs in the inhaled air of municipal police officers sorted by demographic location and sampling period. Note: CB = Ceske Budejovice, PR = Prague, OS = Ostrava; median = the horizontal line in the box; arithmetic mean = the cross in the box; 75th and 25th quartiles = the upper and lower limits of the box; 1.5 × the interquartile range = the length of the whiskers, outside dots = outliers; for results below LOQ and with more than 50% positive samples, a value ½ of LOQ was used; the arrows show statistically significant differences (q > qcrit, α = 0.05)

In the 1st sampling period, the median ∑20 PAHs (5th–95th percentile) for samples from Ceske Budejovice (n = 17) was 1.19 ng/m3 (0.470–4.25 ng/m3), from Prague (n = 60) 1.89 ng/m3 (0.718–3.85 ng/m3) and from Ostrava (n = 56) 2.65 ng/m3 (1.43–8.15 ng/m3), while in the 2nd sampling period the median ∑20 PAHs (5th–95th percentile) for samples from Ceske Budejovice (n = 16) was 1.73 ng/m3 (0.496–6.52 ng/m3), from Prague was (n = 56) 4.23 ng/m3 (1.47–9.09 ng/m3) and from Ostrava (n = 54) was 1.09 ng/m3 (0.427–4.18 ng/m3).

Discussion

Among the levels of OH-PAHs, no statistically significant differences between groups were found. The different metabolic efficiency of the substances in the organism can potentially explain the absence of significant differences between the regions. Another reason could be a process of epigenetic modification represented by a unique DNA methylation pattern previously described in a population from Ostrava chronically exposed to high levels of BaP (Honkova et al. 2022; Rossnerova et al. 2017, 2023).

Since the studied municipal police officers spent a large part of their shift outside, it was hypothesised that air pollution by industry and/or traffic might significantly influence the overall exposure of municipal police officers. For the first round of sampling, detailed information on the time schedule of participants was provided (see Table 2). The samples of urine and filters were divided into groups according to how long the police officers spent outside of the buildings and assessed whether there were statistically significant differences between the measured concentrations. Higher levels of ƩOH-PAHs/ƩPAHs were not observed in the urine/filters of police officers who spent a longer time outside during their shifts.

Based on the knowledge of air pollution in the selected locations (5-year average of annual BaP concentrations: Ceske Budejovice 0.4–2 ng/m3, Prague 0.6–2 ng/m3 and Ostrava > 2 ng/m3) (CHMI 2018), it was hypothesised that the municipal police officers will inhale the concentrations of PAHs during their shift in the order of Ostrava > Prague > Ceske Budejovice. For the 1st sampling period, the order of the cities according to the level of ∑20 PAHs concentrations inhaled by the municipal police officers was as follows: Ostrava* > Prague > Ceske Budejovice (*meets the Tukey-Kraer’s test criterion for a statistically significant difference (q > qcrit, α = 0.05)). The detailed statistical analysis results are presented in Table S7 (one-way ANOVA) and Table S8 (Tukey–Kramer’s test). On the contrary, the weather conditions during the sampling day in Ostrava probably caused the lower measured concentrations of the target analytes in the samples from the 2nd period. They changed the order as follows: Prague* > Ceske Budejovice* > Ostrava* (*meets the Tukey–Kramer’s test criterion for a statistically significant difference (q > qcrit, α = 0.05)).

Considering the respiratory risk associated with PM2.5-bound PAHs, ICR values indicate a high potential risk of cancer in 10.7% of samples in Ostrava (1st sampling round), in 12.5% of samples from CB and in 21.4% of samples from Prague (2nd sampling round).

The Pearson’s correlation coefficient was used to evaluate the relationship between the personal inhalation exposure to parent PAHs and their metabolites in the urine of individual police officers and short-term exposure for both (ƩOH-PAHs and ƩPAHs). Based on the spectrum of target analytes in this study, PHE and PYR with their metabolites Σ5 OH-PHE and 1-OH-PYR were selected. The calculated correlation coefficient rs, which ranged from − 0.124 to 0.194, showed a small, almost negligible relationship (Connelly 2012). No correlation was found between the duration of the time spent outdoor and the measured concentrations of ƩOH-PAHs and ƩPAHs.

In previously published studies looking at the relationship between urinary excretion of OH-PAHs and inhaled PAHs, correlations between PHE/PY and their metabolites were observed in workers with high occupational exposure and smokers (Grimmer et al. 1994; Merlo et al. 1998). However, different results have been demonstrated for non-smokers with non-occupational exposure. In a Portuguese study looking at the impact of indoor air on children in kindergartens exposure to PAHs, no apparent relationships (rs ≤ 0.300) were found for 1-OH-PY and PY. Correlations were observed for low molecular weight naphthalene (NAP) and acenaphthene (AC) with 1-OH-NAP + 1-hydroxyacenaphthene (1-OH-AC) with rs varying from 0.218 to 0.700 (Oliveira et al. 2017). In a Chinese study, university students’ dietary and inhalation exposure to PAHs was investigated. It was found that in addition to 1-OH-PY, metabolites of PHE can also be used as biomarkers for short-term intake of PAHs through diet. Still, for indicating exposure to high molecular weight (with three to seven aromatic rings), PAHs via inhalation 3-hydroxybenzo[a]anthracene (3-OH-BaA) should be used (Zhang et al. 2014).

Based on the above information, these results indicate that inhalation exposure is not a significant source of total exposure to PAHs for Czech municipal police officers. The other significant source of participant’s exposure to PAHs may be from their diet, but its assessment was not part of the study.

Comparison of results from this study with those performed worldwide

The measured concentrations of OH-PAHs in the urine samples of municipal police officers were compared with other studies conducted worldwide (see Table 5). In general, traffic police officers are considered an occupationally exposed group of the population (Hu et al. 2007; Liu et al. 2007; Kamal et al. 2016). Only a few studies addressed urinary biomarker monitoring to assess traffic police officers’ exposure to PAHs (Merlo et al. 1998; Toriba and Hayakawa 2007; Kamal et al. 2016). Given that the monitored municipal police officers were exposed to PAHs from the air and the roads for most of their working hours, they can be considered an occupationally exposed group of the population.

Table 5.

Comparison of presented results of OH-PAHs in the urine with other studies

Country Population group Year of sampling Number of samples Unit 1-OH-NAP 2-OH-NAP 2-OH-FL 2-OH-PHE 3-OH-PHE 4-OH-PHE 1-OH-PHE 9-OH-PHE 1-OH-PY Ref
Italy Traffic police officers 1993–1994 89 Geometric mean (µmol/mol creatinine; µg/g creatinine*) - - - - - - - -

0.14

(0.27)

Merlo et al. 1998
Control subjects (office workers) 43 - - - - - - - -

0.09

(0.17)

Thailand Taxi drivers n.s 10

Geometric mean

(µg/g creatinine)

8.42 2.91 0.55 0.26 0.33 0.03 0.17 0.52 Toriba and Hayakawa 2007
Traffic police officers n.s 10 5.95 3.49 0.60 0.19 0.19 0.05 0.22 0.35
USA

Airforce smokers

(pre-shift)

2008 20 Geometric mean (µg/g creatinine) 3.45 4.63 0.44 0.06 0.10 0.02 n.a 0.12 0.09 Rodrigues et al. 2014

Airforce smokers

(post-shift)

20 6.01 6.38 0.682 0.06 0.11 0.02 n.a 0.12 0.07

Airforce non-smokers

(pre-shift)

18 1.33 2.84 0.25 0.04 0.07 0.02 n.a 0.10 0.07

Airforce non-smokers

(post-shift)

18 2.50 3.56 0.41 0.05 0.08 0.029 n.a 0.11 0.06
USA

Firefighters

(pre-shift)

2008–2009 14

Geometric mean

(µg/g creatinine)

2.09 4.04 0.5 0.25 0.12 n.a 0.2 0.03 0.31 Adetona et al. 2017

Firefighters

(post-shift)

14 8.82 12.07 1.49 0.56 0.35 n.a 0.71 0.12 0.58
Pakistan Traffic police officers 2014 45 Geometric mean (µmol/mol creatinine µg/g creatinine*) - - - - - - - -

0.98

(1.89)

Kamal et al. 2016
Driver workers 50  -  -  -  -  -  -  -  -

0.89

(1.72)

Control subjects 34  -  -  -  -  -  -  -  -

0.7

(1.35)

Czech Republic Women 2013–2014 265

Median

(ng/mL urine;

µg/g creatinine)

0.66 (0.54) 5.95 (5.36) 0.44 (0.37) 0.46 (0.42) 0.21 (0.20) 0.22 (0.18) 0.09 (0.09) 0.11 (0.11) 0.22 (0.21) Urbancova et al. 2017
Czech Republic Women 2016–2017 330

Median

(ng/mL urine;

µg/g creatinine)

0.36 (0.41) 4.62 (5.15) 0.23 (0.23) 0.24 (0.26) 0.15 (0.17) 0.40 (0.45) 0.06 (0.06) 0.15 (0.12) 0.11 (0.12) Urbancova et al. 2020
Czech Republic Police officers 2019 259

Median

(ng/mL urine;

µg/g creatinine)

0.61 (0.41) 4.87 (3.41) 0.44 (0.34) 0.12 (0.09) 0.14 (0.10) 0.03 (0.03) 0.27 (0.20) 0.10 (0.07) 0.12 (0.08) Presented study

n.s. not specified

*µg/g creatinine calculated from µmol/mol creatinine with molar mass for 1-OH-PY 218.25 g/mol and creatinine 113.2 g/mol. Abbreviations of analytes: naphthalene-1-ol (1-OH-NAP), naphthalene-2-ol (2-OH-NAP), fluorene-2-ol (2-OH-FL), phenanthrene-1-ol (1-OH-PHE), phenanthrene-2-ol (2-OH-PHE), phenanthrene-3-ol (3-OH-PHE), phenanthrene-4-ol (4-OH-PHE), phenanthrene-9-ol (9-OH-PHE), pyrene-1-ol (1-OH-PY), benzo[a]pyrene-3-ol (3-OH-BaP), chrysene-6-ol (6-OH-CHRY)

Thus, the worldwide studies selected for the comparison are focused on occupationally exposed individuals. To better understand the exposure of the Czech population, two studies that focus on the analysis of OH-PAHs in urine samples collected from Czech women were also included in the comparison (see below).

As shown in Table 5, the urinary metabolites of NAP, namely 1- and 2-OH-NAP, were the most dominant compounds in all the studies compared. The concentrations of the other target compounds were variable. The PAH concentrations Czech police officers presented in this study are exposed to are at the same level as the general population of the Czech Republic, represented here by Czech women studied in 2013–2014 (Urbancova et al. 2017) and 2016–2017 (Urbancova et al. 2020).

The overall concentration of all monitored OH-PAHs measured in urine samples from Czech police officers presented in this study is comparable to the results published by Rodrigues et al. (2014), specifically with the concentrations of OH-PAHs measured in urine samples from US Airforce workers who smoke, with samples collected pre-shift and with the concentrations of OH-PAHs in urine samples from US Airforce workers who do not smoke, collected post-shift. Similar concentrations of the target compounds were also measured in urine samples from US firefighters (pre-shift) (Adetona et al. 2017).

It can be concluded that Czech police officers are not exposed to such high concentrations of PAHs compared to other highly exposed occupations, e.g. asphalt workers (Buratti et al. 2007), steel workers (Onyemauwa et al. 2009) and coke-oven workers (Campo et al. 2010).

To compare personal inhalation PAH exposure between PAH concentrations determined in this study and previously published data, only studies in which personal air samplers were used were considered and are summarised in Table 6. Since the total number of analytes monitored and the results presented (concentrations in gaseous and/or particulate phase) differ across the studies, the analyte BaP was selected to compare personal inhalation exposure of different population groups.

Table 6.

Comparison of presented results of PAHs in the filters from personal air samplers with other studies

Country Population group Number of samples Unit Sampling period BaP (ng/m3) ΣPAHs (ng/m3) Ref
Finland Bus garage workers 5 air samples from each worker (n = 22) per season Arithmetic mean Winter 2.9 (ND–60) 25 (ND–494)c FL, PHE, AN, FLA, PY, BaA, CHR, BbF, BkF, BaP, DBahA, BghiP and IP Kuusimaki et al. 2003
Summer 0.6 (ND–8.9) 8.5 (ND–46)c
Italy Asphalt workers (AW) and roadside construction workers (CW) AW = 100 Median (min–max) Spring–Summer AW = 0.33 (< 0.03–40.25) AW = 607 (127–2973)a NAP, AC, FL, PHE, AN, FLA, PY, BaA, CHR, BbF, BkF, BaP, DBahA, BghiP and IP Campo et al. 2006
CW = 47 CW = 0.61 (0.04–2.71) CW = 405 (157–940)a
China—Haidian District Traffic police officers 3 air samples per day (10 days in total) Mean Winter 51.9 4300b and 750c NAP, ACL, AC, FL, PHE, AN, FLA, PY, BaA, CHR, BbF, BkF, BaP, DBahA, BghiP and IP Liu et al. 2007
China—Taianjin Traffic policemen 10 Mean Summer 26.2 867.5a FL, PHE, AN, FLA, PY, BaA, CHR, BbF, BkF, BaP, DBahA, BghiP and IP Hu et al. 2007
China Rural home with biomass fuelled cooking: cooking person (CP) + control group in the house (CG) 24 Mean Winter CP = 190 and CG = 46 CP = 1610 and CG = 684c ACL, AC, FL, PHE, AN, FLA, PY, BaA, CHR, BbF, BkF, BaP, DBahA, BghiP and IP Ding et al. 2012
Summer CP = 1.2 and CG = 1.3 n.s
China—Taiyuan Volunteers from rural (RA) and urban areas (UA) 126 Median (interquartile range) Heating season RA = 30.8 (12.3–48.3) and UA = 18.9 (11.5–35) RA = 770 (504–1071) and UA = 695 (540–1051)a ACL, AC, FL, PHE, AN, FLA, PY, BaA, CHR, BbF, BkF, BaP, DBahA, BghiP and IP Duan et al. 2014
Non-heating season RA = 0.101 (0.0913–1.86) and UA = 8.26 (4.74–13.7) RA = 312 (201–412) and UA = 404 (266–544)a
Czech Republic Police officers from three different localities: Ceske Budejovice (CB), Prague (PR) and Ostrava (OS) 259 Median (interquartile range) February–March CB = 0.165 (0.0250–0.634), PR = 0.200 (0.0813–0.472) and OS = 0.287 (0.121–1.13) CB = 1.19 (0.470–4.25), PR = 1.89 (0.718–3.85) and OS = 2.65 (1.43–8.15)c PHE, AN, FLA, PY, BcFL BaA, CPP, CHR, 5MC, BbF, BkF, BjF, BaP, IP DBahA, BghiP, DBaIP, DBaeP, DBaiP, DBahP Presented study
September–October CB = 0.199 (0.0687–0.855), PR = 0.563 (0.178–1.25) and OS = 0.110 (0.0250–0.508) CB = 1.73 (0.496–6.52), PR = 4.23 (1.47–9.09) and OS = 1.09 (0.427–4.18)c

ND not detected

aGaseous and particulate phase

bGaseous phase

cParticulate phase

Abbreviations of analytes: fluorene (FL), naphthalene (NAP), acenaphthene (AC), acenaphthylene (ACL), phenanthrene (PHE), anthracene (AN), fluoranthene (FLA), pyrene (PY), benzo[a]anthracene (BaA), chrysene (CHR), benzo[b]fluoranthene (BbF), benzo[k]fluoranthene (BkF), benzo[a]pyrene (BaP), dibenzo[a,h]anthracene (DBahA), indeno[1,2,3-cd]pyrene (IP), benzo[g,h,i]perylene (BghiP), benzo[c]fluorene (BcFL), cyclopenta[c,d]pyrene (CPP), 5-methylchrysene (5MCH), benzo[j]fluoranthene (BjF), dibenzo[a,l]pyrene (DBalP), dibenzo[a,e]pyrene (DBaeP), dibenzo[a,i]pyrene (DBaiP), dibenzo[a,h]pyrene (DBahP)

Two of these studies focus on the occupational group of traffic police officers from a typical metropolis in China (Hu et al. 2007; Liu et al. 2007). The mean BaP concentrations in these studies were 51.9 and 26.2 ng/m3, respectively, and were approximately 100 × greater than the data in this study. Another study that looked at personal inhalation exposure to PAHs in urban and rural residents during the heating (January–February) and non-heating (September–October) seasons was conducted in China by Duan et al. (2014). Compared to the presented study, BaP concentrations in personal air samples are similar to volunteers from rural areas during the non-heating season (median, 0.101 ng/m3) but much lower than another group of volunteers from urban areas during both heating and non-heating seasons (median 18.9 and 8.26 ng/m3).

An Italian study by Campo et al. (2006) addresses the assessment of inhalation exposure of asphalt and road construction workers to PAHs. The median concentration of BaP for asphalt workers was 0.33 ng/m3, similar to the presented data. Another European study published by Kuusimaki et al. (2003) focused on the analysis of PAHs originating from diesel engine emissions in the personal air samples of bus garage workers. The measured BaP concentrations in samples from summer (mean 0.6 ng/m3) were comparable to the data from this study collected from police officers from Prague in September–October.

Conclusion

This study provides information on the impact of air pollution on the exposure of Czech municipal police officers to PAHs during two seasons (February–March 2019 (1st period) and September–October 2019 (2nd period)). In the 1st period, statistically significant (α = 0.05) higher concentrations of ∑20 PM2.5-bound PAHs were measured in inhaled air of municipal police officers from Ostrava (air polluted location) compared to those from Prague (capital city) and Ceske Budejovice (control location). These results correlate with these locations’ average annual air pollution (CHMI 2018). The 2nd period was affected by windy conditions in Ostrava on the sampling days; therefore, the PAH concentrations in the sampled air were lower than those in other sampling areas. No statistically significant differences in the concentrations of OH-PAHs in the urine of police officers were found.

The results of this study indicate that inhalation exposure is not a major source of the total body burden of PAHs for Czech municipal police officers. The significant source of exposure may be diet. Czech police officers presented are exposed to the same levels of PAHs as the general population of the Czech Republic.

Supplementary Information

Below is the link to the electronic supplementary material.

Acknowledgements

The authors would like to thank the Institute of Experimental Medicine of the Czech Academy of Sciences (Prague, Czech Republic) and the University of Ostrava for providing the samples.

Author contribution

Veronika Gomersall: investigation; formal analysis; writing—original draft; visualisation.

Katerina Ciglova: methodology, writing—review and editing.

Ondrej Parizek: investigation, writing—review and editing.

Andrea Rossnerova: resource, writing—review and editing.

Pavel Rossner Jr.: resource, writing—review and editing.

Radim J. Sram: conceptualisation, project administration, writing—review and editing.

Jan Topinka: conceptualisation; resource; project administration; writing—review and editing; funding acquisition.

Jana Pulkrabova: conceptualisation; writing—review and editing; supervision; funding acquisition.

Funding

Open access publishing supported by the institutions participating in the CzechELib Transformative Agreement. This work was supported by the European Regional Development Fund under Grant Healthy Aging in Industrial Environment HAIE (CZ.02.1.01/0.0/0.0/16_019/0000798). This research has also received funding from the Specific University Research grant No.: A1_FPBT_2020_002.

Data availability

All data are available in our paper or from the corresponding author on reasonable request.

Declarations

Ethical approval

The study was approved by the Ethical Committee of the Institute of Experimental Medicine CAS, October 31, 2018 (No. 2018/09).

Consent to participate

Informed consent was obtained from all subjects involved in the study.

Consent to publish

All authors approved this text.

Conflict of interest

The authors declare no competing interests.

Ethical responsibilities of authors

All authors have read, understood and complied as applicable with the statement on “Ethical responsibilities of Authors” as found in the Instructions for Authors.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. Abdel-Shafy HI, Mansour MSM (2016) A review on polycyclic aromatic hydrocarbons: source, environmental impact, effect on human health and remediation. Egypt J Pet 25:107–123 [Google Scholar]
  2. Adetona O, Simpson CD, Li Z, Sjodin A, Calafat AM, Naeher LP (2017) Hydroxylated polycyclic aromatic hydrocarbons as biomarkers of exposure to wood smoke in wildland firefighters. J Expo Sci Environ Epidemiol 27:78–83 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Buratti M, Campo L, Fustinoni S, Cirla PE, Martinotti I, Cavallo D, Foa V (2007) Urinary hydroxylated metabolites of polycyclic aromatic hydrocarbons as biomarkers of exposure in asphalt workers. J Biomark 12:221–239 [DOI] [PubMed] [Google Scholar]
  4. Bushnik T, Wong SL, Hollowaz AC, Thomson EM (2020) Association of urinary polycyclic aromatic hydrocarbons and obesity in children aged 3–18: Canadian Health Measures Survey 2009–2015. J Dev Orig Health Dis 11:623–631 [DOI] [PubMed] [Google Scholar]
  5. Campo L, Buratti M, Fustinoni S, Cirla P, Martinotti I, Longhi O, Cavallo D, Foa V (2006) Evaluation of exposure to PAHs in asphalt workers by environmental and biological monitoring. Ann N Y Acad Sci 1076:405–420 [DOI] [PubMed] [Google Scholar]
  6. Campo L, Rossella F, Pavanello S, Mielzynska D, Siwinska E, Kapka L, Bertazzi PA, Fustinoni S (2010) Urinary profiles to assess polycyclic aromatic hydrocarbons exposure in coke-oven workers. Toxicol Lett 192:72–78 [DOI] [PubMed] [Google Scholar]
  7. CHMI (2018) Czech Hydrometeorological Institute. Air pollution on the territory of the Czech Republic in 2017; https://www.chmi.cz/files/portal/docs/uoco/isko/grafroc/17groc/gr17cz/Obsah_CZ.html (in Czech)
  8. Connelly L (2012) Correlations. Medsurg Nurs Off J Acad 21:171–172 [PubMed] [Google Scholar]
  9. Ding J, Zhong J, Yang Y, Li B, Shen G, Su Y, Wang C, Li W, Shen H, Wang B, Wang R, Huang Y, Zhang Y, Cao H, Yhu Y, Simonich SLM, Tao S (2012) Occurrence and exposure to polycyclic aromatic hydrocarbons and their derivatives in a rural Chinese home through biomass fuelled cooking. Environ Pollut 169:160–166 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Duan X, Wang B, Yhao X, Shen G, Xia Y, Huang N, Jiang Q, Lu B, Xu D, Fang J, Tao S (2014) Personal inhalation exposure to polycyclic aromatic hydrocarbons in urban and rural residents in a typical northern city in China. Indoor Air 24:464–473 [DOI] [PubMed] [Google Scholar]
  11. EFSA (2008) Scientific panel members Scientific opinion of the panel on contaminants in the food chain on a request from the European commission on polycyclic aromatic hydrocarbons in Food. The EFSA Journal 724:1–114 [Google Scholar]
  12. Grimmer G, Dettbarn G, Naujack KW, Jacob J (1994) Relationship between inhaled PAH and urinary excretion of phenanthrene, pyrene and benzo[a]pyrene metabolites in coke plant workers. Polycyclic Aromat Compd 5:269–277 [Google Scholar]
  13. HAIE - Healthy Aging in Industrial Environment (n.d) Výzkum Vlivu Života v Průmyslovém Prostředí a Znečištění Ovzduší na Zdraví a Stárnutí Obyvatel. Available online: https://haie.osu.cz/en/main-page/. Accessed 5 Apr 2022 (in Czech)
  14. Honkova K, Rossnerova A, Chvojkova I, Milcova A, Margaryan H, Pastorkova A, Ambroz A, Rossner P Jr, Jirik V, Rubes J, Sram RJ, Topinka J (2022) Genome-wide DNA methylation in policemen working in cities differing by major sources of air pollution. Int J Mol Sci 23:1666 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hu Y, Bai Z, Zhang L, Wang X, Zhang X, Tan Z (2007) Health risk assessment for traffic policemen exposed to polycyclic aromatic hydrocarbons (PAHs) in Tianjin. China Sci Total Environ 382:240–250 [DOI] [PubMed] [Google Scholar]
  16. IARC. List of Classifications. IARC Monographs on the Identification of Carcinogenic Hazards to Humans. https://monographs.iarc.who.int/list-of-classifications Accessed 09 March 2021
  17. Kamal A, Cincinelli A, Martellini T, Malik R (2016) Linking mobile source-PAHs and biological effects in traffic police officers and drivers in Rawalpindi (Pakistan). Ecotoxicol Environ Saf 127:135–143 [DOI] [PubMed] [Google Scholar]
  18. Koch H, Aylward L, Hays S, Smolders R, Moos R, Cocker J et al (2014) Inter- and intra-individual variation in urinary biomarker concentrations over a 6-day sampling period. Part 2: Personal care product ingredients. Toxicol Lett 231:261–269 [DOI] [PubMed] [Google Scholar]
  19. Kuusimaki L, Peltonen K, Mutane P, Savela K (2003) Analysis of particle and vapour phase PAHs from the personal air samples of bus garage workers exposed to diesel exhaust. Ann Occup Hyg 47:389–398 [DOI] [PubMed] [Google Scholar]
  20. Lankova D, Urbancova K, Sram RJ, Hajslova J, Pulkrabova J (2016) A novel strategy for the determination of polycyclic aromatic hydrocarbon monohydroxylated metabolites in urine using ultra-high-performance liquid chromatography with tandem mass spectrometry. Anal Bioanal Chem 408:2515–2525 [DOI] [PubMed] [Google Scholar]
  21. Li Z, Mulholland J, Romanoff L, Pittman E, Trinidad D, Lewin M et al (2010) Assessment of non-occupational exposure to polycyclic aromatic hydrocarbons through personal air sampling and urinary biomonitoring. J Environ Monit 12:1110–1118 [DOI] [PubMed] [Google Scholar]
  22. Liu Y, Tao S, Yang Y, Dou H, Yang Y, Coveney R (2007) Inhalation exposure of traffic police officers to polycyclic aromatic hydrocarbons (PAHs) during the winter in Beijing, China. Sci Total Environ 383:98–105 [DOI] [PubMed] [Google Scholar]
  23. Louro H, Gomes B, Saber A, Iamiceli A, Göen T, Jones K et al (2022) The use of human biomonitoring to assess occupational exposure to PAHs in Europe: a comprehensive review. Toxics 10:480 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Merlo F, Andreassen A, Weston A, Pan CF, Haugen A, Valerio F, Reggiardo G, Fontana V, Garte S, Puntoni R, Abbondandolo A (1998) Urinary excretion of 1-hydroxypyrene as a marker for exposure to urban air levels of polycyclic aromatic hydrocarbons. Cancer Epidemiol Biomark Prev 7:147–155 [PubMed] [Google Scholar]
  25. Nethery E, Wheeler A, Fisher M, Sjödin A, Li Z, Romanoff L et al (2012) Urinary polycyclic aromatic hydrocarbons as a biomarker of exposure to PAHs in air: a pilot study among pregnant women. J Expo Sci Environ Epidemiol 22:70–81 [DOI] [PubMed] [Google Scholar]
  26. Nisbet ICT, Lagoy PK (1992) Toxic equivalency factors (tefs) for polycyclic aromatic-hydrocarbones (pahs). Regul Toxicol Pharmacol 16:290–300 [DOI] [PubMed] [Google Scholar]
  27. Oliveira M, Slezakova K, Delerue-Matos C, Pereira MC, Morais S (2017) Assessment of exposure to polycyclic aromatic hydrocarbons in preschool children: levels and impact of preschool indoor air onexcretion of main urinary monohydroxyl metabolites. J Hazard Mater 322:357–369 [DOI] [PubMed] [Google Scholar]
  28. Onyemauwa F, Rappaport SM, Sobus JR, Gajdosova D, Wu R, Waidyanatha S (2009) Using liquid chromatography–tandem mass spectrometry to quantify monohydroxylated metabolites of polycyclic aromatic hydrocarbons in urine. J Chromatogr B 877:1117–1125 [DOI] [PubMed] [Google Scholar]
  29. Perico A, Gottardi M, Boddi V, Bavazzano P, Lanciotti E (2010) Assessment of exposure to polycyclic aromatic hydrocarbons in police in Florence, Italy, through personal air sampling and biological monitoring of the urinary metabolite 1-hydroxypyrene. Arch Environ Health 56:506–512 [DOI] [PubMed] [Google Scholar]
  30. Polachova A, Gramblicka T, Parizek O, Sram RJ, Stupak M, Hajslova J, Pulkrabova J (2020) Estimation of human exposure to polycyclic aromatic hydrocarbons (PAHs) based on the dietary and outdoor atmospheric monitoring in the Czech Republic. Environ Res 182:108977 [DOI] [PubMed] [Google Scholar]
  31. Poursafa P, Dadvand P, Amin MM, Hajizadeh Y, Ebrahimpour K, Mansourin M, Pourzamani H, Sunyer J, Kelishadi R (2018) Association of polycyclic aromatic hydrocarbons with cardiometabolic risk factors and obesity in children. Environ Int 118:203–210 [DOI] [PubMed] [Google Scholar]
  32. Purcaro G, Moret S, Conte SL (2013) Overview on polycyclic aromatic hydrocarbons: Occurrence, legislation and innovative determination in foods. Talanta 105:292–305 [DOI] [PubMed] [Google Scholar]
  33. Ravanbakhsh M, Yousefi H, Lak E, Ansari MJ, Suksatan W, Qasim QA et al (2023) Effect of polycyclic aromatic hydrocarbons (PAHs) on respiratory diseases and the risk factors related to cancer. Polycyclic Aromat Compd 43:8371–8387 [Google Scholar]
  34. Rodrigues EG, Smith K, Maule MAL, Sjodin A, Li Z, Romanoff ML, Kelsey K, Proctor S, McClean MD (2014) Urinary polycyclic aromatic hydrocarbon (OH-PAH) metabolite concentrations and the effect of GST polymorphisms among US Air Force personnel exposed to jet fuel. Occup Environ Med 56:465 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Rossnerova A, Pokorna M, Svecova V, Sram RJ, Topinka J, Zölzer F, Rossner P Jr (2017) Adaptation of the human population to the environment: current knowledge, clues from Czech cytogenetic and “omics” biomonitoring studies and possible mechanisms. Mutat Res 773:188–203 [DOI] [PubMed] [Google Scholar]
  36. Rossnerova A, Elzeinova F, Chvojkova I, Honkova K, Sima M, Milcova A, Pastorkova A, Schmuczerova J, Rossner P Jr, Topinka J, Sram RJ (2023) Effects of various environments on epigenetic settings and chromosomal damage. Environ Pollut 323:121290 [DOI] [PubMed] [Google Scholar]
  37. Sram RJ, Binkova B, Dostal M, Merkerova-Dostalova M, Libalova H, Milcova A, Rossner P Jr, Rossnerova A (2013) Health impact of air pollution to children. Int J Hyg Environ Health 216:533–540 [DOI] [PubMed] [Google Scholar]
  38. Standards - Air Quality - Environment - European Commission [WWW Document] (n.d) URL https://ec.europa.eu/environment/air/quality/standards.htm. Accessed 20 Feb 2022
  39. Sun K, Song Y, He F, Jing M, Tang J, Liu R (2021) A review of human and animals exposure to polycyclic aromatic hydrocarbons: health risk and adverse effects, photo-induced toxicity and regulating effect of microplastics. Sci Total Environ 773:145403 [DOI] [PubMed] [Google Scholar]
  40. Toriba A, Hayakawa K (2007) Biomarkers of exposure to polycyclic aromatic hydrocarbons and related compounds. J Health Sci 53:631–638 [Google Scholar]
  41. Urbancova K, Lankova D, Rossner P, Rossnerova A, Svecova V, Tomaniova M, Veleminsky M, Sram RJ, Hajslova J, Pulkrabova J (2017) Evaluation of 11 polycyclic aromatic hydrocarbon metabolites in urine of Czech mothers and newborns. Sci Total Environ 577:212–219 [DOI] [PubMed] [Google Scholar]
  42. Urbancova K, Dvorakova D, Gramblicka T, Sram RJ, Hajslova J, Pulkrabova J (2020) Comparison of polycyclic aromatic hydrocarbon metabolite concentrations in urine of mothers and their newborns. Sci Total Environ 723:138116 [DOI] [PubMed] [Google Scholar]
  43. WHO U (2000) Air quality guidelines for Europe. WHO Reg Publ Eur Ser 10: 1–273. https://iris.who.int/bitstream/handle/10665/107335/9789289013581-eng.pdf?sequence=1 [PubMed]
  44. Williams RW, Watts RR, Stevens RK, Stone CL, Lewtas J (1999) Evaluation of a personal air sampler for twenty-four hour collection of fine particles and semivolatile organics. J Exposure Anal Environ Epidemiol 9:158–166 [DOI] [PubMed] [Google Scholar]
  45. Xia Y, Zhu P, Han Y, Lu C, Wang S, Gu A, Fu G, Zhao R, Song L, Wang X (2009) Urinary metabolites of polycyclic aromatic hydrocarbons in relation to idiopathic male infertility. Hum Reprod 24:1067–1074 [DOI] [PubMed] [Google Scholar]
  46. Yang P, Wang Y, Sun L, Chen Y, Liu C, Huang L, Lu W, Zeng Q (2017) Urinary metabolites of polycyclic aromatic hydrocarbons, sperm DNAdamage and spermatozoa apoptosis. J Hazard Mater 329:241–248 [DOI] [PubMed] [Google Scholar]
  47. Zhang Y, Ding J, Shen G, Zhong J, Wang C, Wei S, Chen C, Chen Y, Lu Y, Shen H, Li W, Huang Y, Chen H, Su S, Li N, Wang X, Liu W, Tao S (2014) Dietary and inhalation exposure to polycyclic aromatic hydrocarbons and urinary excretion of monohydroxy metabolites - a controlled case study in Beijing, China. Environ Pollut 184:515–522 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data Availability Statement

All data are available in our paper or from the corresponding author on reasonable request.


Articles from Environmental Science and Pollution Research International are provided here courtesy of Springer

RESOURCES